We are live on ! Find out more
IMUX icon

Immunic
IMUX

59 hedge funds and large institutions have $36.9M invested in Immunic in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $34M → $36.9M (+$2.93M)

2% more funds holding

Funds holding: 58 → 59 (+1)

8% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 13

7% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 14

0.09% more ownership

Funds ownership: 5.49% → 5.58% (+0.09%)

90% less call options, than puts

Call options by funds: $55K | Put options by funds: $545K

Holders
59
Holders Change
+1
Holders Change %
+1.72%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
15
Reduced
14
Closed
13
Calls
$55K
Puts
$545K
Net Calls
-$490K
Net Calls Change
-$707K

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$4.69M
2
UOC
UBS O'Connor
Illinois
+$1.27M
3
Millennium Management
Millennium Management
New York
+$989K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$806K
5
RI
RTW Investments
New York
+$804K

Top Sellers

Rank Fund Capital Flow
1
CC
Commodore Capital
New York
-$2.52M
2
AFM
Anson Funds Management
Texas
-$931K
3
GPP
Great Point Partners
Connecticut
-$885K
4
RCM
RA Capital Management
Massachusetts
-$885K
5
CAC
Cowen and Company
New York
-$804K
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
1
RTW Investments
New York
$6.4M +$804K +43,317 +11%
DTC
2
Deep Track Capital
Connecticut
$3.76M +$4.69M +252,424 New
OFM
3
Omega Fund Management
Massachusetts
$2.66M – – –
GC
4
Gratus Capital
Georgia
$2.47M -$23.9K -1,288 -0.8%
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.24M +$806K +43,425 +41%
AG
6
Artal Group
Luxembourg
$1.9M – – –
Millennium Management
7
Millennium Management
New York
$1.88M +$989K +53,308 +73%
BI
8
BVF Inc
California
$1.71M – – –
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$1.06M – – –
UOC
10
UBS O'Connor
Illinois
$1.02M +$1.27M +68,613 New
IC
11
Ikarian Capital
Texas
$969K – – –
VC
12
Vivo Capital
California
$942K – – –
Verition Fund Management
13
Verition Fund Management
Connecticut
$807K +$26K +1,402 +3%
Morgan Stanley
14
Morgan Stanley
New York
$781K +$93K +5,010 +11%
AC
15
AWH Capital
Texas
$745K – – –
PHP
16
Parkman Healthcare Partners
Connecticut
$685K – – –
LGM
17
Logos Global Management
California
$628K +$782K +42,118 New
Two Sigma Advisers
18
Two Sigma Advisers
New York
$596K -$308K -16,610 -29%
Renaissance Technologies
19
Renaissance Technologies
New York
$562K +$701K +37,746 New
Geode Capital Management
20
Geode Capital Management
Massachusetts
$549K +$182K +9,816 +36%
BlackRock
21
BlackRock
New York
$549K +$3.15K +170 +0.5%
CAC
22
Cowen and Company
New York
$533K -$804K -43,316 -55%
SCM
23
Soleus Capital Management
Connecticut
$447K +$557K +30,000 New
Two Sigma Investments
24
Two Sigma Investments
New York
$433K +$17.8K +960 +3%
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$253K -$61K -3,284 -16%
1
2 3

IMUX Hedge Fund Activity: Q1 2023 in Review

59 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q1 2023, worth a combined $36.9M — up 8.6% from $34M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new IMUX positions and 13 closed out — a net gain of 1 holder — while 15 added to existing stakes and 14 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $4.69M. The largest seller was Commodore Capital, exiting entirely with an estimated $2.52M sold.

  • 59 institutional investors held Immunic (IMUX) as of Q1 2023, up from 58 in Q4 2022.
  • Funds reported $36.9M of Immunic stock for Q1 2023, up 8.6% quarter-over-quarter.
  • 14 funds opened new Immunic positions in Q1 2023 and 13 closed out, a net change of +1 holder.
  • The largest Immunic buyer in Q1 2023 was Deep Track Capital, an estimated $4.69M added.
  • The largest Immunic seller in Q1 2023 was Commodore Capital, an estimated $2.52M sold.

Based on aggregated 13F filings for Q1 2023.